Gavin Marx

Australian National University

Australia

Research Interests

Explore related searches

Professors in Australia Professors in Medical Imaging Medical Imaging professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (8)

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Collaborators (7)

Alison Zhang

Macquarie University

AUSTRALIA

View details

Adam Brufsky

University of Pittsburgh Medical Center

UNITED STATES

View details

Nicholas Ngui

Clinical Associate Professor

Australian National University

AUSTRALIA

View details

Peter Fox

Senior Lecturer

University of Western Sydney

AUSTRALIA

View details

Thomas Hughes

Associate Professor

Australian National University

AUSTRALIA

View details

John Boyages

Macquarie University

AUSTRALIA

View details

Sebastien Hotte

McMaster University

CANADA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Gavin Marx

Research Interests

Explore related searches

Contact this professor

Articles (8)

Testosterone suppression plus enzalutamide versus testosterone suppression plus standard antiandrogen therapy for metastatic hormone-sensitive prostate cancer (ENZAMET): an international, open-label, randomised, phase 3 trial

Pertuzumab study in the neoadjuvant setting for HER2‐positive nonmetastatic breast cancer in Australia (PeRSIA)

Physical activity behaviors in cancer survivors treated with neurotoxic chemotherapy

The Utility of the Oncotype DX Test for Breast Cancer Patients in an Australian Multidisciplinary Setting

Final findings from the CONTROL trial: Strategies to reduce the incidence and severity of neratinib-associated diarrhea in patients with HER2-positive early-stage breast cancer

Overall survival of men with metachronous metastatic hormone-sensitive prostate cancer treated with enzalutamide and androgen deprivation therapy

Pathological outcomes of HER2‐positive non‐metastatic breast cancer patients treated with neoadjuvant dual anti‐HER2 therapy and taxane: An Australian experience

Taxane-induced peripheral neuropathy: differences in patient report and objective assessment

Collaborators (7)

Alison Zhang

Adam Brufsky

Nicholas Ngui

Peter Fox

Thomas Hughes

John Boyages

Sebastien Hotte

Make your next move.